by Co-Diagnostics | Dec 14, 2018 | News Release
SALT LAKE CITY–(BUSINESS WIRE)–Co-Diagnostics, Inc. (Nasdaq: CODX), a diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, announced today that it has been awarded a patent from the United Kingdom...
